Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)

Background: Lung cancer is the number one cause of mortality among all types of cancer worldwide. Its treatment landscape has shifted from the classic chemotherapy alone to newer regimens based on the discovery of new immunotherapy and targeted therapy drugs. However, chemotherapy is still an option...

Descripción completa

Detalles Bibliográficos
Autores principales: Assi, Hazem I., Zerdan, Maroun Bou, Hodroj, Mohammad, Khoury, Makram, Naji, Nour Sabiha, Amhaz, Ghid, Zeidane, Reine Abou, El Karak, Fadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219655/
https://www.ncbi.nlm.nih.gov/pubmed/37235814
http://dx.doi.org/10.18632/oncotarget.28444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219655/
https://www.ncbi.nlm.nih.gov/pubmed/37235814
http://dx.doi.org/10.18632/oncotarget.28444

Ejemplares similares